Since 1982, Myong Chong has been defining the most effective modalities to skincare research and development.  Myong established a product testing alliance with Dr. Gracy, Chairman of Biochemistry and Dean of Research at the University of North Texas Health Science Center, where a patented human skin tissue equivalent was implemented to measure safety and efficacy of products.  The launch of the SOVAS 5 Medical Skin Care System characterized by 9 years of intensive research proved revolutionary.  The transdermal delivery of five (5) potent natural ingredients nourish deep within the epidermis and cellular infrastructure. Her progressive approach to treatment led to the origination of two skincare patents that address the necessary functions for overall skin reform through healing and rejuvenation.   U.S. patented transdermal firming formulation marked the first and only skin therapy that “breaks through” the superficial layers of the skin and dynamically impacts the skin’s growth cells.  The second U.S. patent corners the skincare market with a clinically proven skin healing formulation.  Among those that seek after Myong’s anti-aging methods are international dignitaries and celebrities.